Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 2479602, 14 pages
https://doi.org/10.1155/2018/2479602
Research Article

Pretreatment with Shuanghe-Tang Extract Attenuates Postischemic Brain Injury and Edema in a Mouse Model of Stroke: An Analysis of Medicinal Herbs Listed in Dongui Bogam

1Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam 50612, Republic of Korea
2Korean Medical Science Research Center for Healthy Aging, Pusan National University, Yangsan, Gyeongnam 50612, Republic of Korea
3Graduate Training Program of Korean Medicine for Healthy Aging, Pusan National University, Yangsan, Gyeongnam 50612, Republic of Korea
4Division of Humanities and Social Medicine, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam 50612, Republic of Korea

Correspondence should be addressed to Jin Ung Baek; rk.ca.nasup@nagajkum and Hwa Kyoung Shin; rk.ca.nasup@eiluj

Received 1 August 2017; Accepted 31 October 2017; Published 11 February 2018

Academic Editor: Angel Catalá

Copyright © 2018 Min Jae Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Donnan, M. Fisher, M. Macleod, and S. M. Davis, “Stroke,” Lancet, vol. 371, no. 9624, pp. 1612–1623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Guilbert, “The world health report 2002 - reducing risks, promoting healthy life,” Education for Health: Change in Learning & Practice, vol. 16, no. 2, p. 230, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. S. Alper, M. Malone-Moses, J. S. McLellan, K. Prasad, and E. Manheimer, “Thrombolysis in acute ischaemic stroke: time for a rethink?” BMJ, vol. 350, no. mar17 3, p. h1075, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. D. X. Kong, X. J. Li, and H. Y. Zhang, “Where is the hope for drug discovery? Let history tell the future,” Drug Discovery Today, vol. 14, no. 3-4, pp. 115–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. E. Koehn and G. T. Carter, “The evolving role of natural products in drug discovery,” Nature Reviews. Drug Discovery, vol. 4, no. 3, pp. 206–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. B. H. May, C. Lu, L. Bennett, H. M. Hugel, and C. C. Xue, “Evaluating the traditional Chinese literature for herbal formulae and individual herbs used for age-related dementia and memory impairment,” Biogerontology, vol. 13, no. 3, pp. 299–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Choi, B. T. Choi, H. K. Shin, B. C. Shin, Y. K. Han, and J. U. Baek, “Establishment of a comprehensive list of candidate antiaging medicinal herb used in Korean medicine by text mining of the classical Korean medical literature, “dongeuibogam,” and preliminary evaluation of the antiaging effects of these herbs,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 873185, 2015. View at Google Scholar
  8. M. Y. Park, Y. S. Jung, J. H. Park et al., “PMC-12, a prescription of traditional Korean medicine, improves amyloid beta-induced cognitive deficits through modulation of neuroinflammation,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 768049, 2015. View at Google Scholar
  9. B. C. Yun, S. B. Pae, Y. K. Han et al., “An analysis of the combination frequencies of constituent medicinal herbs in prescriptions for the treatment of stroke in Korean medicine: determination of a group of candidate prescriptions for universal use,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 2674014, 17 pages, 2016. View at Google Scholar
  10. T. M. Woodruff, J. Thundyil, S. C. Tang, C. G. Sobey, S. M. Taylor, and T. V. Arumugam, “Pathophysiology, treatment, and animal and cellular models of human ischemic stroke,” Molecular Neurodegeneration, vol. 6, no. 1, p. 11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. D. Huber, R. D. Egleton, and T. P. Davis, “Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier,” Trends in Neurosciences, vol. 24, no. 12, pp. 719–725, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. W. Lee, W. J. Kim, Y. K. Choi et al., “SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier,” Nature Medicine, vol. 9, no. 7, pp. 900–906, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Shi, L. Zhang, H. Pu et al., “Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury,” Nature Communications, vol. 7, p. 10523, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Toni, M. Fiorelli, M. Gentile et al., “Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis,” Archives of Neurology, vol. 52, no. 7, pp. 670–675, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Kirk, J. Plumb, M. Mirakhur, and S. McQuaid, “Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination,” The Journal of Pathology, vol. 201, no. 2, pp. 319–327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Chu, C. Huang, H. Ding et al., “Aquaporin-4 and cerebrovascular diseases,” International Journal of Molecular Sciences, vol. 17, no. 8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Chu, X. Yang, C. Huang, Z. Gao, Y. Tang, and Q. Dong, “Apelin-13 protects against ischemic blood-brain barrier damage through the effects of aquaporin-4,” Cerebrovascular Diseases, vol. 44, no. 1-2, pp. 10–25, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Hirt, B. Ternon, M. Price, N. Mastour, J. F. Brunet, and J. Badaut, “Protective role of early aquaporin 4 induction against postischemic edema formation,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 2, pp. 423–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Hirt, A. M. Fukuda, K. Ambadipudi et al., “Improved long-term outcome after transient cerebral ischemia in aquaporin-4 knockout mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 37, no. 1, pp. 277–290, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. H. I. Lee, S. W. Lee, N. G. Kim et al., “Low-level light emitting diode (LED) therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke,” Journal of Biophotonics, vol. 10, no. 11, pp. 1502–1513, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Li, K. K. Blizzard, Z. Zeng, A. C. DeVries, P. D. Hurn, and L. D. McCullough, “Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender,” Experimental Neurology, vol. 187, no. 1, pp. 94–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. B. Seo, B. K. Kang, J. H. Kim et al., “Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, p. 157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. D. W. Lim, C. Lee, I. H. Kim, and Y. T. Kim, “Anti-inflammatory effects of total isoflavones from Pueraria lobata on cerebral ischemia in rats,” Molecules, vol. 18, no. 9, pp. 10404–10412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Son, M. J. Kim, W. Y. Chung et al., “Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase,” Cancer Letters, vol. 280, no. 1, pp. 86–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Lee, J. H. Lee, E. Y. Oh et al., “Ethanol extract of Cnidium officinale exhibits anti-inflammatory effects in BV2 microglial cells by suppressing NF-κB nuclear translocation and the activation of the PI3K/Akt signaling pathway,” International Journal of Molecular Medicine, vol. 32, no. 4, pp. 876–882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ojha, M. Golechha, S. Kumari, J. Bhatia, and D. S. Arya, “Glycyrrhiza Glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function,” Experimental and Toxicologic Pathology, vol. 65, no. 1-2, pp. 219–227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Jia, W. Y. Gao, Y. Q. Yan et al., “The rediscovery of ancient Chinese herbal formulas,” Phytotherapy Research, vol. 18, no. 8, pp. 681–686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Zhou, S. W. Seto, D. Chang et al., “Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research,” Frontiers in Pharmacology, vol. 7, p. 201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Kim, N. H. Yim, M. Im et al., “Ssanghwa-tang, an oriental herbal cocktail, exerts anti-melanogenic activity by suppression of the p38 MAPK and PKA signaling pathways in B16F10 cells,” BMC Complementary and Alternative Medicine, vol. 13, no. 1, p. 214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. E. A. Neuwelt, B. Bauer, C. Fahlke et al., “Engaging neuroscience to advance translational research in brain barrier biology,” Nature Reviews. Neuroscience, vol. 12, no. 3, pp. 169–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. B. T. Hawkins and T. P. Davis, “The blood-brain barrier/neurovascular unit in health and disease,” Pharmacological Reviews, vol. 57, no. 2, pp. 173–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. C. V. Borlongan, L. E. Glover, P. R. Sanberg, and D. C. Hess, “Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapy,” Current Pharmaceutical Design, vol. 18, no. 25, pp. 3670–3676, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Fukuda and J. Badaut, “Aquaporin 4: a player in cerebral edema and neuroinflammation,” Journal of Neuroinflammation, vol. 9, no. 1, p. 279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Badaut, A. M. Fukuda, A. Jullienne, and K. G. Petry, “Aquaporin and brain diseases,” Biochimica et Biophysica Acta, vol. 1840, no. 5, pp. 1554–1565, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. G. T. Manley, M. Fujimura, T. Ma et al., “Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke,” Nature Medicine, vol. 6, no. 2, pp. 159–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Meng, M. Qiao, L. Lin, M. R. Del Bigio, B. Tomanek, and U. I. Tuor, “Correspondence of AQP4 expression and hypoxic-ischaemic brain oedema monitored by magnetic resonance imaging in the immature and juvenile rat,” The European Journal of Neuroscience, vol. 19, no. 8, pp. 2261–2269, 2004. View at Publisher · View at Google Scholar · View at Scopus